An observational cohort study in renal cell carcinoma and soft tissue sarcoma patients to identify the number of patients at risk of suboptimal treatment due to low exposure.
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Leiomyosarcoma; Nerve sheath neoplasms; Renal cell carcinoma; Soft tissue sarcoma; Synovial sarcoma
- Focus Pharmacokinetics; Therapeutic Use
- 02 Jan 2018 New trial record
- 01 Dec 2017 Results of exposure response analysis published in the Cancer Chemotherapy and Pharmacology